Tag: Pfizer Limited
Pfizer launches PCV20 in India to protect adults against pneumococcal disease
Approved for use in adults 18 years of age and older, Pfizer’s vaccine protects against more serotypes of pneumococcal disease than any other conjugate vaccine previously available in India
Pfizer INDovation program to incubate & commercialize Indian healthcare startups launched
Customized incubation support across technology incubation centers like the IITs and other major technology institutes across India; grant upto Rs. 65 lakh per selected start-up
Budget could include Research-Linked Incentive scheme to fast track pharma growth:...
S Sridhar, President, OPPI and Managing Director, Pfizer Limited shares his budget 2022-23 reaction